Donanemab: The Breakthrough Drug Ushering a New Era in Alzheimer’s Treatment
A new Alzheimer's drug, Donanemab shows a 35% slowdown in cognitive decline.
Tag: alzheimer's drug
Experimental Alzheimer’s drug connected to third death in trials
Science writes “As enthusiasm mounts for a new experimental antibody that appears to slow cognitive decline in some Alzheimer’s patients, a third death linked to…
Research shows that Niacin limits Alzheimer’s Disease progression in lab disease models.
Science Daily writes that recent research published by Indiana University School of Medicine “found that Niacin limits Alzheimer’s disease progression when used in models in…
Medicare makes changes to coverage of controversial Alzheimer’s drug Aduhelm
According to CNN article published April 7th, 2022 “Medicare will restrict coverage of the controversial and costly Alzheimer’s drug Aduhelm to those enrolled in qualifying clinical trials,…